Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
1.280
-0.060 (-4.48%)
At close: Oct 8, 2024, 4:00 PM
1.260
-0.020 (-1.56%)
After-hours: Oct 8, 2024, 5:03 PM EDT
Verrica Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -86.93 | -67 | -24.49 | -35.08 | -42.69 | -28.21 | |
| Depreciation & Amortization | 1.1 | 0.84 | 0.72 | 0.47 | 0.23 | 0.26 | |
| Loss (Gain) From Sale of Assets | 2.68 | 2.54 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | - | - | 0.11 | 0.07 | -0.14 | -1.06 | |
| Stock-Based Compensation | 16.04 | 14.38 | 4.99 | 6.05 | 9.82 | 3.33 | |
| Other Operating Activities | 1.81 | 0.81 | 1.83 | 1.44 | 0.94 | - | |
| Change in Accounts Receivable | -10.04 | -3.93 | -0.49 | - | - | - | |
| Change in Accounts Payable | -0.63 | 2.2 | -0.34 | 0.5 | -0.84 | 0.23 | |
| Change in Unearned Revenue | - | - | - | -0.5 | 0.5 | - | |
| Change in Other Net Operating Assets | 10.35 | 11.59 | -0.98 | -0.53 | 1.97 | -1.95 | |
| Operating Cash Flow | -65.62 | -38.58 | -18.65 | -27.58 | -30.21 | -27.41 | |
| Capital Expenditures | -0.3 | -0.36 | -0.3 | -0.88 | -1.47 | -0.68 | |
| Investment in Securities | - | - | 54.52 | 0.09 | -1.89 | 27.86 | |
| Other Investing Activities | - | - | -0.18 | -0.2 | -0.22 | -1.22 | |
| Investing Cash Flow | -0.3 | -0.36 | 54.04 | -1 | -3.58 | 25.96 | |
| Long-Term Debt Issued | - | 44.11 | - | 4.98 | 34.46 | - | |
| Long-Term Debt Repaid | - | -0.02 | -43.75 | -0.01 | - | - | |
| Net Debt Issued (Repaid) | 43.75 | 44.08 | -43.75 | 4.97 | 34.46 | - | |
| Issuance of Common Stock | 0.15 | 30.31 | 26.9 | 28.68 | 0.45 | 0.42 | |
| Other Financing Activities | -1.19 | -0.18 | -0.02 | - | 0.32 | - | |
| Financing Cash Flow | 42.72 | 74.21 | -16.87 | 33.65 | 35.23 | 0.42 | |
| Net Cash Flow | -23.21 | 35.27 | 18.52 | 5.07 | 1.45 | -1.03 | |
| Free Cash Flow | -65.93 | -38.94 | -18.95 | -28.47 | -31.68 | -28.09 | |
| Free Cash Flow Margin | -474.01% | -759.93% | -209.83% | -237.21% | - | - | |
| Free Cash Flow Per Share | -1.42 | -0.86 | -0.55 | -1.05 | -1.27 | -1.13 | |
| Cash Interest Paid | 6.84 | 3.15 | 1.79 | 2.85 | 1.88 | - | |
| Levered Free Cash Flow | -37.69 | -17.12 | -11.08 | -18 | -16.9 | -16.77 | |
| Unlevered Free Cash Flow | -32.29 | -14.64 | -9.73 | -15.32 | -15.01 | -16.77 | |
| Change in Net Working Capital | 0.17 | -10.02 | 1.82 | 1.65 | -1.53 | 0.88 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.